Gene · 3783
Papers2,742
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,742
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Brain organoids: from unguided to regionalized to nucleus-specific. | Life Med | 2024 | 39872659 | PubTator, text mining | PubMed |
| Construction and evaluation of a prognostic model for metabolism-related genes in kidney renal clear cell carcinoma using TCGA database. | Am J Clin Exp Urol | 2024 | 39839750 | PubTator, text mining | PubMed |
| Peptide Lv and Angiogenesis: A Newly Discovered Angiogenic Peptide. | Biomedicines | 2024 | 39767758 | PubTator, text mining | PubMed |
| AP-1 activates KCNN4-mediated Ca2+ signaling to induce the Th1/Th17 differentiation of CD4+ cells in chronic non-bacterial prostatitis. | Cell Biol Toxicol | 2024 | 39729199 | PubTator, text mining | PubMed |
| Cell modeling using frequency modulation. | PLoS One | 2024 | 39642158 | PubTator, text mining | PubMed |
| The novel quinoline derivative SKA-346 as a KCa3.1 channel selective activator. | RSC Adv | 2024 | 39635364 | PubTator, text mining | PubMed |
| Uncovering immune cell-associated genes in breast cancer: based on summary data-based Mendelian randomized analysis and colocalization study. | Breast Cancer Res | 2024 | 39614330 | PubTator, text mining | PubMed |
| Identification and validation of ion channels-related mRNA prognostic signature for glioblastomas. | Medicine (Baltimore) | 2024 | 39612412 | PubTator, text mining | PubMed |
| Inhibition of K+ Channels Affects the Target Cell Killing Potential of CAR T Cells. | Cancers (Basel) | 2024 | 39594705 | PubTator, text mining | PubMed |
| Time-Dependent Relationship Between Endothelial Dysfunction and High Blood Pressure in Fructose Drinking Rats. | Turk J Pharm Sci | 2024 | 39569662 | PubTator, text mining | PubMed |
| Gene expression profiles of neuroinflammatory responses in broad brain regions in rats repeatedly administered with N-methyl-N-nitrosourea for 28 days. | J Toxicol Sci | 2024 | 39496385 | PubTator, text mining | PubMed |
| Intermediate conductance calcium-activated potassium channel (KCa3.1) in cancer: Emerging roles and therapeutic potentials. | Biochem Pharmacol | 2024 | 39396649 | PubTator, text mining | PubMed |
| ACYP2 functions as an innovative nano-therapeutic target to impede the progression of hepatocellular carcinoma by inhibiting the activity of TERT and the KCNN4/ERK pathway. | J Nanobiotechnology | 2024 | 39267048 | PubTator, text mining | PubMed |
| Somatostatin peptides prevent increased human colonic epithelial permeability induced by hypoxia. | Am J Physiol Gastrointest Liver Physiol | 2024 | 39226584 | PubTator, text mining | PubMed |
| Phospholipid scrambling induced by an ion channel/metabolite transporter complex. | Nat Commun | 2024 | 39217145 | PubTator, text mining | PubMed |
| Ca2+-permeable AMPA receptor-dependent silencing of neurons by KCa3.1 channels during epileptiform activity. | Biochem Biophys Res Commun | 2024 | 39068818 | PubTator, text mining | PubMed |
| Calcium-activated Potassium Channels as Amplifiers of TRPV4-mediated Pulmonary Edema Formation in Male Mice. | Anesthesiology | 2024 | 39042042 | PubTator, text mining | PubMed |
| Atrial fibroblast-derived exosomal miR-21 upregulate myocardial KCa3.1 via the PI3K-Akt pathway during rapid pacing. | Heliyon | 2024 | 39040331 | PubTator, text mining | PubMed |
| The role of potassium ion channels in chronic sinusitis. | Front Pharmacol | 2024 | 39015366 | PubTator, text mining | PubMed |
| ER-to-lysosome Ca2+ refilling followed by K+ efflux-coupled store-operated Ca2+ entry in inflammasome activation and metabolic inflammation. | Elife | 2024 | 38953285 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3783/papers?page=7